Evidence map›Paper›PMID 23471344›Full record

SynthesisHerz2013

Catheter ablation of atrial fibrillation to reduce stroke risk.

B Schmidt, S Bordignon, A Fürnkranz, K R J Chun

Abstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Herz, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

B SchmidtCardioangiologisches Centrum Bethanien, Wilhelm-Epstein Str. 4, 60431, Frankfurt am Main, Deutschland. b.schmidt@ccb.de
S Bordignon
A Fürnkranz
K R J Chun
Angiologica (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is the most devastating complication of atrial fibrillation (AF), and the latter increases the risk of stroke by almost fivefold. AF elimination by catheter ablation should lower the risk of thromboembolic complications. Several studies support this hypothesis, demonstrating rates of stroke in AF patients similar to non-AF populations after successful catheter ablation. Widespread discontinuation of oral anticoagulation after catheter ablation is currently not supported by scientific data but it may be a viable option for patients with a CHA2DS2VASc score of less than 2 and a well-documented stable sinus rhythm.

Indexed as

Atrial FibrillationCatheter AblationCausalityComorbidityHumansRisk AssessmentRisk Reduction BehaviorStrokeSurvival RateTreatment Outcome

Identifiers

PMID23471344
OpenAlexW1759753321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.